{
    "startDate": "2018-01-01",
    "endDate": "2018-03-31",
    "year": "2018",
    "quarter": "Q1",
    "symbol": "AVEO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 16160000
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 10835000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 600000
            },
            {
                "label": "Insurance recovery (Note 9)",
                "concept": "EstimatedInsuranceRecoveries",
                "unit": "usd",
                "value": 15000000
            },
            {
                "label": "Clinical trial retainers current.",
                "concept": "aveo:ClinicalTrialRetainersCurrent",
                "unit": "usd",
                "value": 836000
            },
            {
                "label": "Other prepaid expenses and other assets current.",
                "concept": "aveo:OtherPrepaidExpensesAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 171000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 43602000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 11000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 43613000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 3380000
            },
            {
                "label": "Accrued clinical trial costs and contract research current.",
                "concept": "aveo:AccruedClinicalTrialCostsAndContractResearchCurrent",
                "unit": "usd",
                "value": 7337000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1962000
            },
            {
                "label": "Loans payable, net of discount",
                "concept": "LoansPayableCurrent",
                "unit": "usd",
                "value": 586000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 1342000
            },
            {
                "label": "Deferred research and development reimbursement current.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementCurrent",
                "unit": "usd",
                "value": 706000
            },
            {
                "label": "Estimated settlement liability (Note 9)",
                "concept": "LossContingencyAccrualCarryingValueCurrent",
                "unit": "usd",
                "value": 17115000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 32428000
            },
            {
                "label": "Loans payable, net of current portion and discount",
                "concept": "LongTermLoansPayable",
                "unit": "usd",
                "value": 18002000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 4085000
            },
            {
                "label": "Deferred research and development reimbursement noncurrent.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementNoncurrent",
                "unit": "usd",
                "value": 143000
            },
            {
                "label": "PIPE warrant liability (Note 7)",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 38110000
            },
            {
                "label": "Other liabilities (Note 6)",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1090000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 93858000
            },
            {
                "label": "Preferred stock, $.001 par value: 5,000 shares authorized at March 31, 2018 and December 31, 2017; no shares issued and outstanding at each of March 31, 2018 and December 31, 2017",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $.001 par value: 250,000 shares authorized at March 31, 2018 and December 31, 2017; 118,867 and 118,325 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 119000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 548308000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -4000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -598668000
            },
            {
                "label": "Stockholders\u2019 deficit:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -50245000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 43613000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8988000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 583000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "PaidInKindInterest",
                "unit": "usd",
                "value": 111000
            },
            {
                "label": "Non-cash change in fair value of PIPE warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 1465000
            },
            {
                "label": "Settlement costs (Note 9)",
                "concept": "LitigationSettlementExpense",
                "unit": "usd",
                "value": 42000
            },
            {
                "label": "Amortization of premium and discount on investments",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -5000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 198000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -249000
            },
            {
                "label": "Other noncurrent assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": -4000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 944000
            },
            {
                "label": "Increase decrease in accrued contract research.",
                "concept": "aveo:IncreaseDecreaseInAccruedContractResearch",
                "unit": "usd",
                "value": -984000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": -496000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 1019000
            },
            {
                "label": "Increase decrease in deferred research and development reimbursement.",
                "concept": "aveo:IncreaseDecreaseInDeferredResearchAndDevelopmentReimbursement",
                "unit": "usd",
                "value": -274000
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -6518000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 6801000
            },
            {
                "label": "Proceeds from maturities and sales of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 14537000
            },
            {
                "label": "Investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 7736000
            },
            {
                "label": "Proceeds from issuance of common stock, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 518000
            },
            {
                "label": "Proceeds from issuance of stock for stock-based compensation arrangements",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Payment of end-of-term debt costs (Note 6)",
                "concept": "PaymentsOfFinancingCosts",
                "unit": "usd",
                "value": 540000
            },
            {
                "label": "Financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -7000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 1211000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 509000
            },
            {
                "label": "Increase to deferred revenue due to adoption of ASC Topic 606 - transition adjustment on January 1, 2018",
                "concept": "NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification",
                "unit": "usd",
                "value": 2711000
            }
        ],
        "ic": [
            {
                "label": "Collaboration and licensing revenue",
                "concept": "LicenseAndServicesRevenue",
                "unit": "usd",
                "value": 980000
            },
            {
                "label": "Partnership royalties",
                "concept": "RoyaltyRevenue",
                "unit": "usd",
                "value": 46000
            },
            {
                "label": "Revenues:",
                "concept": "Revenues",
                "unit": "usd",
                "value": 1026000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 5404000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2610000
            },
            {
                "label": "Settlement costs (Note 9)",
                "concept": "LitigationSettlementExpense",
                "unit": "usd",
                "value": 42000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 8056000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -7030000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 493000
            },
            {
                "label": "Change in fair value of PIPE warrant liability",
                "concept": "AdjustmentOfWarrantsGrantedForServices",
                "unit": "usd",
                "value": 1465000
            },
            {
                "label": "Other expense, net:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -1958000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -8988000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8988000
            },
            {
                "label": "Net loss per share \u2014 basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.08
            },
            {
                "label": "Weighted average number of common shares outstanding",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 118840000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -8988000
            }
        ]
    }
}